When support systems collide: Disability insurance and the management of functional neurologic disorder

Notice: Blog posts are not subject to review by MedLink Neurology’s Editorial Board. MedLink acknowledges using artificial intelligence to assist in the creation of blog posts.

The intersection of functional neurologic disorder and disability insurance presents clinical and ethical challenges that neurologists regularly navigate. Although functional neurologic disorder is common and may often be disabling, its entanglement with compensation systems raises difficult questions about diagnosis, legitimacy, and long-term management.

What is functional neurologic disorder?

Functional neurologic disorder refers to neurologic symptoms (eg, nonepileptic seizures, functional limb weakness, tremor, or gait disturbance) that are inconsistent with known structural disease and demonstrate positive clinical features, such as entrainment of tremor or give-way weakness. It is constructively diagnosed, not by exclusion. Functional neurologic disorder is believed to be a disorder of brain function—not fabrication or malingering—and often arises in the setting of stress, trauma, or other medical illness.

Functional neurologic disorder versus malingering

Malingering refers to the intentional feigning of symptoms for external gain, such as financial compensation or avoidance of responsibility. It is rare in neurology and is not the same as functional neurologic disorder, where symptoms are believed to be involuntary and distressing, despite lacking structural explanation.

Whereas functional neurologic disorder is diagnosed by positive clinical signs, malingering is a behavioral judgment often inferred in legal or forensic settings when clear evidence of deception exists. Physicians must be cautious about applying this label, which has ethical and legal implications.

Real disability versus simulated disability in functional neurologic disorder

Patients with functional neurologic disorder can have significant functional impairment—loss of ability to work, drive, or live independently—even in the absence of structural damage. This constitutes real disability. Simulated disability, by contrast, implies intentional exaggeration or falsification, which requires clear and corroborated evidence.

Disability insurance: complicating or supporting care?

Disability systems can both support recovery and inadvertently reinforce illness behavior:

• Repeated assessments may entrench an “illness identity.”
• Patients may resist improvement if it threatens benefit continuation.
• Clinicians may hesitate to assign a functional neurologic disorder diagnosis when litigation is active, fearing patient backlash or misinterpretation by insurers.

Despite these tensions, most patients with functional neurologic disorder are believed not to be malingering and deserve access to therapeutic interventions, such as physical therapy, cognitive behavioral therapy, and psychiatric support.

Ethical dilemmas in testing and patient demands

When patients demand neuroimaging (eg, MRI) and threaten legal action if refused, physicians should:

• Document clinical reasoning clearly.
• Offer shared decision-making, explaining why imaging is unlikely to change management.
• Avoid unnecessary testing unless a medico-legal context justifies it.

Ordering tests purely due to fear of litigation may propagate unnecessary interventions and reinforce unhelpful illness beliefs. On the other hand, it would be prudent for physicians to consider the risks of litigation in choosing their actions.

Challenging behaviors: a non-neurologic complication

Some patient behaviors—persistent demands for unnecessary treatments, threats, refusal to engage in therapy—can undermine care relationships. Physicians should respond with:

• Clear boundaries and respectful communication.
• Referral to psychiatry or behavioral medicine when needed.
• Support from institutional ethics or risk management teams in complex cases.

Persistently uncooperative patients and those engaged in unacceptable behaviors or speech may be discharged from the practice.

How is disability determined?

Disability eligibility is typically assessed by insurers or government agencies based on:

• Functional limitation in activities of daily living or work.
• Medical documentation, often including clinician statements, therapy notes, and test results.
• Degree of impairment rather than the specific diagnosis.

Functional neurologic disorder can qualify as a disabling condition if it results in sustained loss of function.

Should society pay to treat functional neurologic disorder?

Yes—functional neurologic disorder is treatable, and outcomes improve when patients have access to specialized, multidisciplinary care. Denying care due to stigma or misunderstanding increases chronicity, healthcare costs, and functional decline. Public and private payers should support evidence-based treatment for functional neurologic disorder just as they do for structural neurologic disorder.

Conclusion

Functional neurologic disorder is believed to be a genuine neurologic disorder with disabling potential, deserving of clinical validation and therapeutic support. Disability insurance limitations can shape how it is presented, interpreted, and managed. Neurologists must navigate these tensions with clarity, empathy, and firm clinical judgment, while advocating for access to appropriate care.

Related MedLink Neurology Podcasts:

• The Neurotransmitters: Perspectives - Functional Neurologic Disorders with FND Life
• Neuro Podcases: Functional neurological disorder
  
• The Neurotransmitters: Perspectives - Functional Neurologic Disorders
  

Are you interested in contributing a post or becoming a guest blogger for MedLink? Contact us at editorial@medlink.com.